ClinicalTrials.gg
Drug

Dulaglutide clinical trials

Also written LY2189265.

studies test it
78
open now
9
in phase 3
25
first study started
2008

How each study uses dulaglutide is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the dulaglutide studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
18 Sept 2014 · TRULICITY · BLA 125469 (FDA, Drugs@FDA)
European Union
21 Nov 2014 · Trulicity · EMEA/H/C/002825 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Dulaglutide
64
Trulicity
9
dulaglutide injection
4
Dulaglutide 0.75mg subcutaneous injection
2
Dulaglutide 0.75Mg/0.5Ml Inj Pen
2

Development codes

LY2189265
42

Studies by the year they started

78 studies that test it; most in 2010 (8)

Studies that test dulaglutide, by start year
YearStudies
20083
20091
20108
20118
20128
20131
20141
20151
20165
20175
20182
20194
20205
20216
20225
20234
20243
20257
20261

Who runs them

Industry 47 · Other 31

Eli Lilly and Company (45) · University Hospital, Basel, Switzerland (4) · Zagazig University (2) · Ain Shams University (2) · Emory University (2) · Attikon Hospital (1) · Fundación para la Investigación del Hospital Clínico de Valencia (1) · CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. (1)

Often tested with

Tested in the same studies.

Semaglutide (2) · Tirzepatide (2) · Empagliflozin (2) · Nisotirostide (2) · DPP-4 inhibitors (1) · Metformin (1) · Canagliflozin (1) · Dapagliflozin (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 3 phase 3 studies under way

Dulaglutide is the comparator. A study of two new drugs counts under both.

  • 1HS-20094 · Jiangsu Hansoh Pharmaceutical Co., Ltd. · next primary completion Mar 2027
  • 1Orforglipron · Eli Lilly and Company · next primary completion Mar 2030
Reaching primary completion within a year · 3

Studies that test dulaglutide.

Studies

Open first, then newest update. How each study uses dulaglutide is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 78

See all 78 studies that test dulaglutide →

Given beside what is tested · 2 — dulaglutide is usual care or a partner of the new treatment
As the comparator · 25 — what is tested is compared with dulaglutide

Showing 20 of 25.

Codes

What other systems call dulaglutide · ClinicalTrials.gg INT005774

  • MeSH (NLM) C555680dulaglutideConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) WTT295HSY5DULAGLUTIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 1551291Confirmed FDA, Wikidata
  • Wikidata Q21011228dulaglutideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C169923DulaglutideOne source FDA
  • DrugBank DB09045One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.